A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging

Silvia Giordano1, Valentina Pifferi2, Lavinia Morosi3

  • 1Environmental Health Sciences Department, Mass Spectrometry Laboratory, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milano, Italy. silvia.giordano@marionegri.it.

Insights

This study enhances drug imaging in oncology using novel nanomaterial matrices for Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging (MALDI-MSI). Nanoparticles and nanotubes improve drug detection sensitivity and reproducibility in tumors.

Area of Science:

  • Pharmacology and Oncology
  • Analytical Chemistry
  • Materials Science

Background:

  • Accurate drug distribution imaging in tumors is crucial for effective cancer treatment.
  • Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging (MALDI-MSI) offers simultaneous visualization of multiple compounds in tissues.
  • The selection of an appropriate matrix is critical for MALDI-MSI sensitivity and analyte-specific ionization efficiency.

Purpose of the Study:

  • To improve MALDI-MSI techniques for pharmacological applications.
  • To develop nanostructured surfaces as novel matrices for enhanced drug imaging.
  • To achieve high sensitivity and reproducibility in visualizing drug distribution within tumor tissues.

Main Methods:

  • Screening of nanomaterials (gold nanoparticles, titanium nanoparticles, halloysites, carbon nanotubes) as potential MALDI matrices.
  • Evaluation of drug signal intensity and signal-to-noise ratio by co-spotting nanomaterials with drugs.
  • Testing selected nanomaterials on tumor slices to assess ion suppression effects and drug distribution in vivo.

Main Results:

  • Several nanomaterials demonstrated potential as effective matrices for drug imaging via MALDI-MSI.
  • Nanostructured surfaces showed improved drug signal intensity and signal-to-noise ratios compared to traditional matrices.
  • Preliminary in vivo studies confirmed the utility of the best-performing nanomaterials for drug distribution analysis in tumors.

Conclusions:

  • Nanomaterials offer a promising alternative to conventional matrices for enhancing MALDI-MSI in drug development.
  • The developed nanostructured surfaces facilitate sensitive and reproducible imaging of drug distribution in tumor models.
  • This approach holds significant potential for optimizing oncology drug efficacy assessment.

Related Concept Videos